Reporting quality of randomized controlled trials in patients with HIV on antiretroviral therapy: a systematic review

被引:0
作者
Kaori Nagai
Akiko M. Saito
Toshiki I. Saito
Noriyo Kaneko
机构
[1] Nagoya City University,Department of Global and Community Health, Graduate School of Nursing
[2] Clinical Research Center,Department of Clinical Research Management
[3] National Hospital Organization Nagoya Medical Center,undefined
来源
Trials | / 18卷
关键词
HIV/AIDS; ART; Randomized controlled trials; CONSORT; Reporting quality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 76 条
[1]  
Begg C(1996)Improving the quality of reporting of randomized controlled trials. The CONSORT statement JAMA. 276 637-9
[2]  
Moher D(2001)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials Lancet. 357 1191-4
[3]  
Schulz KF(2010)CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials BMJ 340 c332-50
[4]  
Altman DG(2010)CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials BMJ. 340 c869-85
[5]  
Schulz KF(2004)Better reporting of harms in randomized trials: an extension of the CONSORT statement Ann Intern Med. 141 781-82
[6]  
Altman DG(2009)Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review J Antimicrob Chemother. 64 239-23
[7]  
Moher D(2014)Reporting of critical information in studies of pharmacists in HIV care Int J Pharm Pract. 22 375-41
[8]  
Moher D(2013)Deficient reporting and interpretation of non-inferiority randomized clinical trials in HIV patients: a systematic review PLoS One. 8 214-92
[9]  
Hopewell S(2011)Randomized controlled trials of HIV/AIDS prevention and treatment in Africa: results from the Cochrane HIV/AIDS Specialized Register PLoS One. 6 875-79
[10]  
Schulz KF(2011)Failure to report protocol violations in clinical trials: a threat to internal validity? Trials. 12 21-57